Syngene International Limited
SYNGENE · General/Diversified · NSE
₹437
Current Market Price
Fair Value (DCF)
₹255
Margin of Safety
-41.7%
Updated just now
YieldIQ Score
43/100
Piotroski F-Score
6/9
Economic Moat
Narrow
Confidence
46%
ROE
10.5%
Debt/Equity
0.00
WACC
12.8%
Market Cap
₹0.18 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
13.1%
Return on capital employed
EV / EBITDA
17.1×
Enterprise multiple
Debt / EBITDA
0.6×
Leverage vs earnings
Interest Coverage
14.4×
EBIT covers interest
Current Ratio
1.64×
Short-term liquidity
Asset Turnover
0.53×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
10.7%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹437.1
Bear case
₹157.94
MoS -176.8%
Base case
₹254.93
MoS -71.5%
Bull case
₹317.39
MoS -37.7%
Ratio Trends
SYNGENE · last 7 annual periods
ROE
10.5%
ROCE
21.5%
Operating Margin
—
Debt / Equity
0.12×
PE
133.7×
EV / EBITDA
24.0×
Historical Financials
SYNGENE · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹2184 Cr | ₹2601 Cr | ₹994 Cr | ₹917 Cr | ₹3513 Cr | +12.6% |
| EBITDA | — | ₹812 Cr | ₹995 Cr | ₹1092 Cr | ₹1142 Cr | +8.9% |
| EBIT | ₹497 Cr | ₹506 Cr | ₹241 Cr | ₹222 Cr | — | -18.3% |
| PAT | ₹405 Cr | ₹394 Cr | ₹179 Cr | ₹189 Cr | ₹496 Cr | +5.2% |
| EPS (diluted) | ₹10.11 | ₹9.77 | ₹4.43 | ₹4.69 | — | -17.5% |
| CFO | ₹701 Cr | ₹582 Cr | ₹824 Cr | ₹1042 Cr | ₹1168 Cr | +13.6% |
| CapEx | — | — | — | — | ₹-770 Cr | — |
| FCF | — | — | — | — | ₹398 Cr | +0.0% |
| Total Assets | — | ₹5564 Cr | ₹5831 Cr | ₹6152 Cr | ₹6796 Cr | +5.1% |
| Total Debt | — | — | ₹86.3 Cr | ₹41.7 Cr | ₹578 Cr | +60.9% |
| Shareholders' Equity | — | — | ₹3618 Cr | ₹4258 Cr | ₹4727 Cr | +6.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SYNGENE vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| VIJAYA VIJAYA | — | — | Pending | 17.9% | — |
| METROPOLIS METROPOLIS | — | — | Pending | 10.9% | — |
| THYROCARE THYROCARE | — | — | Pending | 16.7% | — |
Click a ticker to view its fair-value analysis.
Dividend History
7 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹4.75/sh
Last payout
2025-06-27
₹1.25
Peak payout
₹1.25
Trailing yield
0.29%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. Syngene International Limited (SYNGENE.NS) trades at 437.10 vs a model fair value of 254.93, a gap of -41.7%. Piotroski F-score: 6/9. Moa...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of SYNGENE →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SYNGENE →
Compare
Head-to-head with peers
Compare SYNGENE side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SYNGENENow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.